Q2 2016 13F Holders as of 30 Jun 2016
-
Type / Class
-
Equity / COM
-
Total 13F shares
-
2,187,688
-
Share change
-
-573,405
-
Total reported value
-
$14,984,007
-
Price per share
-
$6.85
-
Number of holders
-
23
-
Value change
-
-$4,829,932
-
Number of buys
-
12
-
Number of sells
-
21
Institutional Holders of ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) as of Q2 2016
As of 30 Jun 2016,
ZYNERBA PHARMACEUTICALS INC - COM (ZYNE) was held by
23 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
2,187,688 shares.
The largest 10 holders included
PERCEPTIVE ADVISORS LLC, Cormorant Asset Management, LLC, RA CAPITAL MANAGEMENT, LLC, VANGUARD GROUP INC, EMERALD ADVISERS INC/PA, NEXTHERA CAPITAL LP, AUXIER ASSET MANAGEMENT, BlackRock Fund Advisors, Alpine Partners VI, LLC, and CREDIT SUISSE AG/.
This page lists
23
institutional shareholders reporting positions in this security
for the Q2 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.